1-203181202-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The ENST00000255409.8(CHI3L1):c.671G>A(p.Arg224Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00031 in 1,614,112 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
ENST00000255409.8 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CHI3L1 | NM_001276.4 | c.671G>A | p.Arg224Gln | missense_variant | 7/10 | ENST00000255409.8 | NP_001267.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CHI3L1 | ENST00000255409.8 | c.671G>A | p.Arg224Gln | missense_variant | 7/10 | 1 | NM_001276.4 | ENSP00000255409 | P1 | |
CHI3L1 | ENST00000404436.2 | c.161G>A | p.Arg54Gln | missense_variant | 2/4 | 2 | ENSP00000385350 | |||
CHI3L1 | ENST00000472064.1 | n.195G>A | non_coding_transcript_exon_variant | 2/3 | 2 | |||||
CHI3L1 | ENST00000473185.1 | n.933G>A | non_coding_transcript_exon_variant | 1/2 | 2 |
Frequencies
GnomAD3 genomes AF: 0.000158 AC: 24AN: 152128Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000227 AC: 57AN: 251396Hom.: 0 AF XY: 0.000236 AC XY: 32AN XY: 135860
GnomAD4 exome AF: 0.000326 AC: 477AN: 1461866Hom.: 0 Cov.: 31 AF XY: 0.000289 AC XY: 210AN XY: 727232
GnomAD4 genome AF: 0.000158 AC: 24AN: 152246Hom.: 0 Cov.: 33 AF XY: 0.000161 AC XY: 12AN XY: 74452
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 01, 2021 | The c.671G>A (p.R224Q) alteration is located in exon 7 (coding exon 7) of the CHI3L1 gene. This alteration results from a G to A substitution at nucleotide position 671, causing the arginine (R) at amino acid position 224 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at